期刊文献+

胃癌同时性肝转移手术患者的预后分析 被引量:13

Prognostic analysis of patients with synchronous liver metastasis from gastric cancer following simultaneous gastric and liver resection
原文传递
导出
摘要 目的分析经手术治疗的胃癌同时性肝转移患者的预后因素。方法回顾性分析1998年1月至2012年12月间在大连医科大学附属第一医院胃肠外科手术治疗的胃癌同时性肝转移53例患者的临床病理学资料,对单发和多发肝转移患者的生存率进行比较并进行预后分析。结果本组53例患者5年总体生存率为11.3%。单发肝脏转移患者34例,5年生存率14.7%,明显高于19例多发肝转移患者的0(P=-0.000)。单因素分析结果显示,浆膜侵犯(P=0.000)、淋巴结转移(P=0.000)、手术根治度(P=0.044)、发生肝转移数目(P=0.000)和肝转移肿瘤直径(P=0.031)是影响胃癌肝转移患者预后的因素。其中浆膜侵犯(RR:3。355,P=0.012)和肝转移数目(RR:7.664,P=0.000)是影响胃癌肝转移患者预后的独立因素。结论手术治疗可以提高无浆膜侵犯的胃癌单发肝转移患者的预后。 Objective To investigate the surgical results of hepatic resection for solitary metastasis form gastric cancer. Methods Clinical data of 53 patients who underwent simultaneous curative gastric and liver resection in our hospital from January 1998 to December 2012 were analyzed retrospectively. Univariate and multivariate analyses were performed to examine independent factors for survival. Results In 53 patients, the accumulated 5-year survival rate after hepatic resection was 11.3%, 14.7% for solitary metastasis and 0 for multiple metastases. The statistically significant prognostic factors affecting 5-year survival rates were found to be serosal invasion (P=0.000), lymph node metastasis (P=0.000), the degree of radical resection (P=0.044), number of hepatic metastases (P= 0.000), liver metastasis size (P=0.031). Multivariate Cox regression analysis showed that the serosal invasion (RR:3.355, P =0.012) and number of hepatic metastasis (RR:7.664, P =0.000) were independent prognostic factors in patients with liver metastasis from gastric cancer. Conclusion The prognosis of solitary metastasis from gastric cancer without serosal invasion can be improved through active radical resection based on suitable indications.
作者 曹亮 胡祥
出处 《中华胃肠外科杂志》 CAS CSCD 2014年第2期124-127,共4页 Chinese Journal of Gastrointestinal Surgery
关键词 胃肿瘤 肝转移 预后 Stomach neoplasms Liver metastasis Prognosis
  • 相关文献

参考文献12

  • 1Tsujimoto H,Ichikura T,Ono S. Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer[J].Hepatol Int,2010.406-413.
  • 2Qiu JL,Deng MG,Li W. Hepatic resection for synchronous hepatic metastasis from gastric cancer[J].{H}EUROPEAN JOURNAL OF SURGICAL ONCOLOGY,2013.694-700.
  • 3Imamura H,Matsuyama Y,Shimada R. A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma[J].{H}American Journal of Gastroenterology,2001.3178-3184.
  • 4Sakamoto Y,Ohyama S,Yamamoto J. Surgical resection of liver metastases of gastric cancer:an analysis of a 17-year experience with 22 patients[J].{H}SURGERY,2003.507-511.
  • 5Ueda K,Iwahashi M,Nakamori M. Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer[J].{H}Langenbecks Archives of Surgery,2009.647-653.
  • 6Baek HU,Kim SB,Cho EH. Hepatic Resection for Hepatic Metastases from Gastric Adenocarcinoma[J].J Gastric Cancer,2013.86-92.
  • 7邓靖宇,梁寒,刘宁,张汝鹏,詹宏杰,王学军,郝希山.胃癌根治术后肝转移的预后分析[J].中华胃肠外科杂志,2008,11(2):145-149. 被引量:6
  • 8Koga R,Yamamoto J,Ohyama S. Liver resection for metastatic gastric cancer:experience with 42 patients including eight long-term survivors[J].{H}Japanese Journal of Clinical Oncology,2007.836-842.
  • 9Sakamoto Y,Sano T,Shimada K. Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer[J].{H}Journal of Surgical Oncology,2007.534-539.
  • 10Cheon SH,Rha SY,Jeung HC. Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases[J].{H}ANNALS OF ONCOLOGY,2008.1146-1153.

二级参考文献31

  • 1孙振华,孙占峰,胡天明.胃癌并局限型肝转移同步切除九例报告[J].中华胃肠外科杂志,2004,7(5):389-391. 被引量:1
  • 2王洪义,李明,顾晋.胃癌肝转移患者的手术治疗及预后分析[J].中华胃肠外科杂志,2005,8(1):11-13. 被引量:22
  • 3陈俊强,詹文华.胃癌肝转移的特点和肝切除术的作用[J].中华胃肠外科杂志,2005,8(1):93-94. 被引量:6
  • 4Das BC, Kawarada Y. Long-term survival after treatment of gastric carcinoma with liver metastases. A case report. Hepatogastroenterology, 2003,50 : 2282-2284.
  • 5Daniele M, Alfonso DS, Giovanni de M, et al. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg, 2005,241 : 247-255.
  • 6Okano K, Meaba T, Ishimura K, et al. Hepatic resection for metastatic tumors from gastric cancer. Ann Surg, 2002,235: 86 -91.
  • 7Sakamoto Y, Ohyama S, Yamamoto J, et al. Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery, 2003,133:507- 511.
  • 8Miyazaki M, Itoh H, Nakagawa K, et al. Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol, 1997,92 : 490-493.
  • 9D'Angelica M, Gonen M, Brennan MF, et al. Patterns of initial recurrence in completely resected gastric adenocarcinoma,Ann Surg, 2004,240 : 808- 816.
  • 10Yoo CH, Noh SH, Shin DW, el al. Recurrence following curative resection for gastric carcinoma. Br J Surg, 2000,87: 236-242.

共引文献10

同被引文献86

  • 1邓薇,沈琳.胃癌靶向药物治疗进展[J].中国医学前沿杂志(电子版),2013,5(1):29-41. 被引量:8
  • 2齐亚灵,王伟群,张建华,赵晓莲,张坤,于海波,贾秀月,齐淑芳,邵明亮.CXC趋化因子配体5对前列腺癌细胞生长的作用[J].中国老年学杂志,2014,34(11):3035-3036. 被引量:5
  • 3吕柯,曹青,宋展.老年胃癌合并腹水患者的临床病理特点及D2根治术对预后的影响[J].中国老年学杂志,2014,34(5):1257-1258. 被引量:3
  • 4Javier Sastre,Jose Angel García-Saenz,Eduardo Díaz-Rubio.Chemotherapy for gastric cancer[J].World Journal of Gastroenterology,2006,12(2):204-213. 被引量:22
  • 5Hwang JE, Kim SH, Jin J, Hong JY, Kim MJ, Jung SH, Shim HJ, Bae WK, Hwang EC, Kim JW, Shin SS, Jeong O, Park YK, Cho SH, Chung IJ. Combination of percutaneous radiofrequency ablation and sys- temic chemotherapy are effective treatment modali- ties for metachronous liver metastases from gastric cancer. Clin Exp Metastasis 2014; 31:25-32 [PMID: 23975154 DOI: 10.1007/s10585-013-9606-5].
  • 6Mourra N, Scriva A, Mansiaux Y, Gozlan S, Bennis M, Balaton A. Clusterin expression in gastrointes- tinal neuroendocrine tumours is highly correlated with location and is helpful in determining the ori- gin of liver metastases. Histopathology 2014 May 7. [Epub ahead of print] [PMID: 24807631 DOI: 10.1111/ his.12450].
  • 7Komeda K, Hayashi M, Kubo S, Nagano H, Nakai T, Kaibori M, Wada H, Takemura S, Kinoshita M, Koga C, Matsumoto M, Sakaguchi T, Inoue Y, Hi- rokawa F, Kwon AH, Uchiyama K. High Survival in Patients Operated for Small Isolated Liver Me- tastases from Gastric Cancer: A Multi-institutional Study. World J Surg 2014; 38:2692-2697 [PMID: 24803345].
  • 8Hu SJ, Jiang RX, Xie HI-I, Ma AL, Shi HL, Shen H, Hao ZM. Purification of a Pd20-TNFa fusion pro- tein that prevents liver metastasis of gastric cancer. Tumour Bio12014; 35:7523-7529 [PMID: 24789430].
  • 9Namikawa T, Shiga M, Ichikawa K, Kitagawa H, Kobayashi M, Hanazaki K. Metachronous liver and bone metastasis from small early gastric carcinoma without lymph node involvement: A case report. Mol Clin Onco12013; 1:249-252 [PMID: 24649155].
  • 10Wei Q, Xu J, Shen L, Fu X, Zhang B, Zhou X, Carls- son J. HER2 expression in primary gastric cancers and paired synchronous lymph node and liver metastases. A possible road to target HER2 with radionuclides. Tumour Biol 2014; 35:6319-6326 [PMID: 24643685 DOI: 10.1007/s13277-014-1830-3].

引证文献13

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部